Earnings Releases

Noble Corp plc updated its first quarter 2024 guidance (reaffirmed).

“On May 6, 2024, Noble Corporation plc (the “Company”) issued a press release announcing its condensed consolidated financial results for the quarter ended March 31, 2024.”

Crescent Energy Co reported the first quarter of 2024 results: net income $32 million. Guidance raised.

“Crescent Energy Company (the “Company”) announced its financial and operating results for the quarter ended March 31, 2024.”

Hour Loop, Inc reported the quarter ended March 31, 2024 results: revenue $24.7 million, net income $1.1 million, EPS $0.03 per diluted share. Guidance initiated.

“retailer, announces its financial and operational results for the quarter ended March 31, 2024. Financial Highlights for First Quarter 2024: ● Net revenues increased 17.2% to $24.7 million, compared to $21.1 million in the year-ago period; ● Net income totaled $1.1 million, compared to net loss of $1.2 million in the year-ago period; and ● Cash provided for”

Rani Therapeutics Holdings, Inc. reported the three months ended March 31, 2024 results: net income Net loss for the three months ended March 31, 2024 was $14.8 million.

“Rani Therapeutics Holdings, Inc. (the “Company”) issued a press release providing a corporate update and announcing its financial results for the three months ended March 31, 2024.”

Zeta Global Holdings Corp. reported the first quarter ended March 31, 2024 results: revenue $195 million, net income $40 million, EPS $0.23. Guidance raised.

“our enterprise and new agency customers. All in, a strong combination going into the second quarter and the rest of the year.” First Quarter 2024 Highlights • Total revenue of $195 million, increased 24% Y/Y. • Scaled Customer count increased to 460 from 452 in 4Q’23 and 411 in 1Q’23. • Super-Scaled Customer count increased to 144 from 131 in 4Q’23 and 110 in”

Omega Therapeutics, Inc. reported first quarter ended March 31, 2024 results: net income $20.1 million.

“Net loss for the first quarter of 2024 was $20.1 million, compared to $25.3 million for the first quarter of 2023.”

Day One Biopharmaceuticals, Inc. reported the quarter ended March 31, 2024 results: net income $62.4 million.

“Day One Biopharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2024.”

Paymentus Holdings, Inc. reported the quarter ended March 31, 2024 results: revenue $184.9 million, net income $7.2 million, EPS $0.06.

“and backlog, supporting our positive outlook for the rest of 2024,” said Dushyant Sharma, Founder and CEO. First Quarter 2024 Financial and Business Highlights • Revenue was $184.9 million, an increase of 24.6% year-over-year, driven largely by increased transactions. • Gross profit was $52.7 million, an increase of 31.6% year-over-year. Adjusted gross profit (1)”

Lucky Strike Entertainment Corp reported third quarter of fiscal year 2024, which ended on March 31, 2024 results: revenue $337.7 million, net income $23.8 million. Guidance reaffirmed.

“entertainment, today provided financial results for the third quarter of the 2024 Fiscal Year, which ended on March 31, 2024. Quarter Highlights: • Revenue increased 7.0% to $337.7 million versus the prior year and increased 64.7% versus 3QFY19 (quarter ended March 31, 2019) • Revenue excluding Service Fee Revenue increased 8.8% to $336.4 million versus the prior”

Vimeo, Inc. updated its the fiscal quarter ended March 31, 2024 guidance (reaffirmed).

“On May 6, 2024, Vimeo, Inc. (the “Company”) issued a shareholder letter (the "Letter") announcing the Company's results for the fiscal quarter ended March 31, 2024.”

Symbotic Inc. reported second fiscal quarter of 2024 ended March 30, 2024 results: revenue $424 million, net income $41 million. Guidance initiated.

“Symbotic posted revenue of $424 million, a net loss of $41 million and adjusted EBITDA 1 of $22 million for the second quarter of fiscal 2024.”

SEMrush Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $85.8 million.

“as expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Semrush Announces First Quarter 2024 Financial Results • First quarter revenue of $85.8 million, up 21% year-over-year • ARR of $354.2 million, up 21% year-over-year • First quarter net cash provided by operating activities of $14.8 million • First quarter free cash flow of”

Finance of America Companies Inc. reported the first quarter ended March 31, 2024 results: net income Net loss from continuing operations of $ 16 million or $0.06 basic loss per share, EPS $0.06 basic loss per share.

“Finance of America Companies Inc. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2024.”

Offerpad Solutions Inc. reported three months ended March 31, 2024 results: revenue $285.4M, net income ($17.5M), EPS ($0.64).

“about what the future holds.” Q1 2024 Financial Results (quarter over quarter) Q1 2024 Q4 2023 Percentage Change Homes acquired 806 678 19% Homes sold 847 712 19% Revenue $285.4M $240.5M 19% Gross profit $22.6M $16.7M 35% Net loss ($17.5M) ($15.4M) (13%) Adjusted EBITDA ($7.1M) ($7.0M) (1%) Diluted Net Loss per Share ($0.64) ($0.57) (12%) Gross profit”

Beachbody Company, Inc. reported the quarter ended March 31, 2024 results: revenue $120.0 million, net income $14.2 million. Guidance initiated.

“• Total revenue was $120.0 million compared to $144.9 million in the prior year period. o Digital revenue was $61.5 million compared to $64.8 million in the prior year period and digital subscriptions totaled 1.22 million in the first quarter. o Nutrition and Other revenue was $55.5 million compared to $74.1 million in the prior year period and nutritional subscriptions totaled 0.15 million in the first quarter. o Connected Fitness revenue was $3.0 million compared to $6.0 million in the prior year period and approximately 3,500 bikes were delivered in the first quarter. • Total operating expenses were $92.1 million compared to $118.8 million in the prior year period. • Operating loss improved by $16.6 million to $10.8 million compared to an operating loss of $27.4 million in the prior year period. • Net loss was $14.2 million compared to a net loss of $29.2 million in the prior year period.”

Aaron's Company, Inc. reported full year 2024 results: revenue Revenues of $2.055 billion to $2.155 billion, EPS Non-GAAP Diluted EPS of $0.00 to $0.25. Guidance raised.

“sequential improvement of 460 basis points • Announced quarterly cash dividend of $0.125 per share to be paid on July 3, 2024 Full Year 2024 Consolidated Outlook: • Revenues of $2.055 billion to $2.155 billion • Adjusted EBITDA 1 of $105.0 million to $125.0 million • Non-GAAP Diluted EPS 1 of $0.00 to $0.25 The Company will host an earnings conference call tomorrow,”

Aaron's Company, Inc. reported first quarter 2024 results: revenue Revenues were $511.5 million, EPS Loss per share was $0.46; Non-GAAP loss per share was $0.15. Guidance reaffirmed.

“of those results and the 2024 outlook are included below, in the attached supplement, and at investor.aarons.com . First Quarter 2024 Consolidated Results: • Revenues were $511.5 million • Adjusted EBITDA 1 was $22.7 million • Loss per share was $0.46; Non-GAAP loss per share 1 was $0.15 • Reaffirms full year 2024 outlook for revenue and adjusted EBITDA and”

PLAYSTUDIOS, Inc. reported first quarter ended March 31, 2024 results: revenue $77.8 million, net income $0.6 million. Guidance reaffirmed.

“First Quarter Financial Highlights • Revenue was $77.8 million during the first quarter of 2024, compared to $80.1 million during the first quarter of 2023. • Net loss was $0.6 million during the first quarter of 2024, representing a net loss margin of (0.7)%, compared to net loss of $2.6 million during the first quarter of 2023, representing a net loss margin of (3.2)%.”

GPGI, Inc. reported first quarter ended March 31, 2024 results: revenue $104.0 million, net income $17.1 million, EPS $0.20 (Basic) and $0.17 (Diluted). Guidance reaffirmed.

“CompoSecure Reports Record First Quarter 2024 Financial Results and Declares Special Cash Dividend Q1 Net Sales up 9% to $104.0 Million; Q1 Net Income up 59% to $17.1 Million;”

Foghorn Therapeutics Inc. reported financial results for the quarter ended March 31, 2024.

“On May 6, 2024, Foghorn Therapeutics Inc. (the “Company”) issued a press release announcing certain of the Company’s financial results for the quarter ended March 31, 2024.”

Rocket Lab Corp reported second quarter of 2024 results: revenue between $105 million and $110 million. Guidance initiated.

“For the second quarter of 2024, Rocket Lab expects: • Revenue between $105 million and $110 million.”

Rocket Lab Corp reported financial results for first quarter ended March 31, 2024.

“Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2024.”

Owlet, Inc. reported first quarter ended March 31, 2024 results: EPS Basic earnings per share was $0.15 for the first quarter of 2024, compared to basic net loss per share of ($1.54) for th.

“Q1 Revenue was approximately $14.8 million, up approximately 37% year over year.”

Matterport, Inc./DE reported financial results for the quarter ended March 31, 2024.

“On May 6, 2024, Matterport, Inc. (the “Company”) issued a press release announcing its financial and operational results for the first quarter of 2024. A copy of the press release is furnished as Exhibit 99.1 hereto.”

Lucid Group, Inc. reported first quarter ended March 31, 2024 results: revenue $172.7 million.

“Lucid reported Q1 revenue of $172.7 million on deliveries of 1,967 vehicles”

ATI Physical Therapy, Inc. reported the first quarter ended March 31, 2024 results: revenue $181.5 million. Guidance reaffirmed.

“are presented after the financial statements at the end of this press release. Commentary on performance results in the first quarter of 2024 is as follows: • Net revenue was $181.5 million compared to $166.9 million in the first quarter of 2023, an increase of 8.7%. ▪ Net patient revenue was $165.4 million compared to $150.8 million in the first quarter of 2023, an”

Assertio Holdings, Inc. updated its three months ended March 31, 2024 guidance (reaffirmed).

“On May 6, 2024, Assertio Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2024.”

Lyell Immunopharma, Inc. reported the first quarter ended March 31, 2024 results: net income net loss of $60.7 million.

“Lyell reported a net loss of $60.7 million for the first quarter ended March 31, 2024, compared to a net loss of $67.0 million for the same period in 2023.”

Lyell Immunopharma, Inc. reported the quarter ended March 31, 2024 results: net income net loss of $60.7 million.

“On May 6, 2024, Lyell Immunopharma, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024.”

Adeia Inc. reported first quarter ended March 31, 2024 results: revenue $83.4 million, net income $0.9 million, EPS $0.01. Guidance reaffirmed.

“in markets that will drive future growth, including in OTT, adjacent media markets, and in our semiconductor business.” First Quarter Financial Highlights • Revenue was $83.4 million as compared to $86.9 million in the fourth quarter of 2023 • GAAP diluted earnings per share (EPS) was $0.01 and non-GAAP diluted EPS was $0.25 • GAAP net income was $0.9 million”

Oric Pharmaceuticals, Inc. reported financial results for for the quarter ended March 31, 2024.

“ORIC Pharmaceuticals, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2024.”

Hims & Hers Health, Inc. reported the first quarter ended March 31, 2024 results: revenue Revenue of $278.2 million, net income Net income of $11.1 million. Guidance raised.

“be expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results Revenue of $278.2 million, up 46% year-over-year in 2024 Net income of $11.1 million; Adjusted EBITDA of $32.3 million in Q1 2024 Subscribers grew to 1.7 million, up 41% year-over-year in Q1 2024 Raises”

BELLRING BRANDS, INC. updated its the second fiscal quarter ended March 31, 2024 guidance (raised).

“On May 6, 2024, BellRing Brands, Inc. (the "Company") issued a press release announcing results for its second fiscal quarter ended March 31, 2024.”

ADC Therapeutics SA reported financial results for the first quarter ended March 31, 2024.

“On May 6, 2024, ADC Therapeutics SA (the “Company”) issued a press release announcing the Company’s financial results for the first quarter ended March 31, 2024.”

Pennant Group, Inc. reported preliminary financial results for the first quarter ended March 31, 2024.

“On May 6, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its first quarter ended March 31, 2024.”

PLIANT THERAPEUTICS, INC. reported first quarter ended March 31, 2024 results: net income Net loss of $47.0 million.

“Pliant Therapeutics, Inc. (the "Company") issued a press release announcing the Company’s financial results for the first quarter ended March 31, 2024.”

Northwest Natural Holding Co reported the first quarter of 2024 results: net income $63.8 million, EPS $1.69 per share. Guidance reaffirmed.

“NW Natural Holdings Reports First Quarter 2024 Results”

VIEMED HEALTHCARE, INC. reported three months ended March 31, 2024 results: revenue $50.6 million, net income $1.6 million.

“Net revenues for the quarter ended March 31, 2024 were $50.6 million , representing an increase of $11.0 million , or 28% , over net revenues reported for the comparable quarter ended March 31, 2023. • Net income for the quarter ended March 31, 2024 totaled $1.6 million.”

TALOS ENERGY INC. updated its the fiscal quarter ended March 31, 2024 guidance (reaffirmed).

“On May 6, 2024, Talos Energy Inc. (the “Company”) issued a press release announcing its financial and operational results for the fiscal quarter ended March 31, 2024.”

Krystal Biotech, Inc. reported the first quarter ending March 31, 2024 results: revenue $45.3 million.

“The Company recorded $45.3 million in VYJUVEK net product revenue for the first quarter of 2024.”

Alpha Metallurgical Resources, Inc. reported first quarter ending March 31, 2024 results: net income $127.0 million, EPS $9.59 per diluted share.

“Reports first quarter net income of $127.0 million, or $9.59 per diluted share”

JELD-WEN Holding, Inc. reported the first quarter ended March 30, 2024 results: revenue $959.1 million, net income $(27.7) million, EPS $(0.32) per share. Guidance reaffirmed.

“the Company's Australasia segment as a discontinued operation, as appropriate and unless otherwise noted. First Quarter Highlights • Net revenues from continuing operations of $959.1 million decreased (11.2%) in the first quarter driven by a (12%) Core Revenue decline as a result of (12%) lower volume/mix due to weak macro-economic conditions. • Net loss from”

Playa Hotels & Resorts N.V. updated its three months ended March 31, 2024 guidance (reaffirmed).

“On May 6, 2024, Playa Hotels & Resorts N.V. (“Playa” or the “Company”) issued a press release reporting the Company’s financial results for the three months ended March 31, 2024.”

Claros Mortgage Trust, Inc. reported the quarter ended March 31, 2024 results: net income ($52.8 million), or ($0.39) per diluted share.

“Claros Mortgage Trust, Inc. Reports First Quarter 2024 Results New York, NY, May 6, 2024 – Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today reported its financial results for the quarter ended March 31, 2024. The Company’s first quarter 2024 GAAP net loss was ($52.8 million), or ($0.39) per diluted share.”

Bain Capital Specialty Finance, Inc. reported first quarter ended March 31, 2024 results: revenue $74.5 million, net income $34.0 million or $0.53 per share, EPS $0.55.

“investments at fair value were in floating rate securities. RESULTS OF OPERATIONS For the three months ended March 31, 2024 and December 31, 2023, total investment income was $74.5 million and $74.9 million, respectively. The decrease in investment income was primarily due to a decrease in interest and dividend income, partially offset by an increase in other”

Shockwave Medical, Inc. reported first quarter ended March 31, 2024 results: revenue $218.8 million, net income $55.3 million, EPS $1.48 and $1.44.

“to bring our life-changing therapies to even more patients across the globe.” First Quarter 2024 Financial Results Revenue for the first quarter ended March 31, 2024, was $218.8 million, a 36% increase from $161.1 million in the same period of 2023. The growth in revenue was primarily driven by increased adoption of Shockwave products in both the United States”

EverQuote, Inc. reported the first quarter ended March 31, 2024 results: revenue $91.1 million, net income GAAP net income improved to $1.9 million. Guidance raised.

“by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 EverQuote Announces First Quarter 2024 Financial Results • First Quarter Revenue of $91.1 million • First Quarter Variable Marketing Margin of $30.8 million • First Quarter Record GAAP Net Income of $1.9 million and Adjusted EBITDA of $7.6 million CAMBRIDGE, Mass., May. 6,”

Lumentum Holdings Inc. reported fiscal third quarter ended March 30, 2024 results: revenue $366.5 million, net income GAAP net loss of $127.0 million, EPS $1.88 per diluted share.

“Net revenue for the fiscal third quarter of 2024 was $366.5 million, with GAAP net loss of $127.0 million, or $1.88 per diluted share.”

Corvus Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2024.

“Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS) (GLOBAL NEWSWIRE), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2024.”

Stoke Therapeutics, Inc. reported the three months ended March 31, 2024 results: revenue $4.2 million, net income $26.4 million, EPS $0.57 per share.

“Revenue recognized for upfront license fees and services provided from a License and Collaboration Agreement with Acadia Pharmaceuticals for the three months ended March 31, 2024 was $4.2 million, compared to $5.2 million, for the same period in 2023.”